The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE). — CFSMEATLAS
The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE).
Pheby, Derek F H, Araja, Diana, Berkis, Uldis et al. · Medicina (Kaunas, Lithuania) · 2021 · DOI
Quick Summary
This European research report examined whether ME/CFS could be prevented and what money might be saved if prevention programs worked. The researchers found that preventing ME/CFS before it starts is very difficult because the illness seems to result from a mix of genetic factors and environmental exposures that we don't fully understand yet. However, they identified that safer use of certain agricultural chemicals like organophosphates could help, and catching ME/CFS earlier through better doctor training could reduce how severe the illness becomes and lower healthcare costs.
Why It Matters
This study is important because it identifies where resources could be most effectively spent to reduce the burden of ME/CFS across Europe. By demonstrating that early diagnosis and secondary prevention hold greater promise than primary prevention, it guides policymakers and health systems toward practical interventions that could improve patient outcomes and reduce the enormous economic costs associated with prolonged illness.
Observed Findings
Primary prevention has limited scope due to ME/CFS arising from complex interactions between host and environmental factors, with host factors appearing dominant.
Organophosphate exposure represents an identifiable modifiable risk factor where Europe-wide health education interventions could be beneficial.
Secondary prevention through earlier diagnosis and reduced diagnostic delay offers the greatest economic and health benefit.
Significant knowledge gaps exist regarding occupational risk factors for ME/CFS.
Diagnostic delays are associated with increased illness severity and elevated healthcare costs.
Inferred Conclusions
Primary prevention of ME/CFS is unlikely to be effective without major advances in understanding host genetic and environmental risk factors.
Secondary prevention through prompt diagnosis should be prioritized as the most achievable and cost-effective intervention strategy.
Europe-wide initiatives promoting safe agricultural chemical use, particularly organophosphates, could prevent some cases.
Future research must focus on identifying modifiable occupational and environmental risk factors to inform prevention strategies.
Remaining Questions
What are the specific host genetic and immune factors that predispose individuals to ME/CFS?
What This Study Does Not Prove
This study does not prove that ME/CFS is completely preventable or identify all causative factors. It also does not establish that primary prevention will never be possible—rather, it reflects current knowledge gaps, meaning future research may uncover modifiable risk factors not yet identified. The findings are based on available evidence and economic models, not on randomized controlled trials of prevention interventions.